Advancements in Targeted Therapy for Oral Cancer: A Mini Review

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Oral cancer management traditionally relies on surgery, radiation, and chemotherapy.
• Emerging targeted therapies offer precision treatment by focusing on specific molecular tumor characteristics.
• These novel approaches aim to improve treatment accuracy and minimize damage to healthy tissues.

Purpose of the Study:

• To review current advancements in targeted therapies for oral cancer.
• To explore the integration of targeted therapies with conventional treatment modalities.
• To highlight the potential of personalized medicine in enhancing therapeutic outcomes and patient survival.

Main Methods:

• Literature review of recent studies on targeted oral cancer therapies.
• Analysis of clinical data on Epidermal Growth Factor Receptor (EGFR) inhibitors.
• Examination of immune checkpoint inhibitors and other biomarker-directed treatments.
• Discussion of combination strategies involving targeted agents and conventional treatments.

Main Results:

• Targeted therapies, including EGFR inhibitors and immune checkpoint inhibitors, show promise in oral cancer management.
• Combination therapies integrating targeted agents with surgery, radiation, and chemotherapy enhance treatment efficacy.
• Biomarker-drug directed strategies are crucial for personalized treatment approaches.
• Personalized medicine demonstrates potential in overcoming drug resistance and improving patient prognosis.

Conclusions:

• Targeted therapy represents a significant advancement in oral cancer treatment, offering precision and improved outcomes.
• Combining targeted therapies with conventional methods enhances efficacy and patient survival.
• Personalized medicine approaches hold a bright future for improving the quality of life for oral cancer patients.